Estrogens in neuropsychiatric disorders: From physiology to pathophysiology

Estrogen Effects in Psychiatric Disorders

Volumn , Issue , 2005, Pages 1-30

  Vedder, Helmut ^a   Behl, Christian ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33845234515     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/3-211-27063-9_1     Document Type: Chapter

References (154)

1. Ames BN (1988) Measuring oxidative damage in humans: relation to cancer and ageing. IARC Sci Publ 89: 407-416.
2. Beal MF (1995) Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 38: 357-366.
3. Becker JB (1999) Gender differences in dopaminergic function in striatum and nucleus accumbens. Pharmacol Biochem Behav 64: 803-812.
4. Beckman KB, Ames BN (1998) The free radical theory of aging matures. Physiol Rev 78: 547-581.
5. Behl C, Holsboer F (1999) The female sex hormone oestrogen as a neuroprotectant. Trends Pharmacol Sci 20: 441-444.
6. Behl C, Skutella T, Lezoualc'h F, Post A, Widmann M, Newton CJ, Holsboer F (1997) Neuroprotection against oxidative stress by estrogens: Structure-Activity relationship. Mol Pharmacol 51: 535-541.
7. Behl C, Widmann M, Trapp T, Holsboer F (1995) 17beta-estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Commun 216: 473-482.
8. Beyer C, Raab H (1998) Nongenomic effects of oestrogen: embryonic mouse midbrain neurones respond with a rapid release of calcium from intracellular stores. Eur J Neurosci 10: 255-262.
9. Bito H, Deisseroth K, Tsien RW (1997) Ca2± dependent regulation in neuronal gene expression. Curr Opin Neurobiol 7: 419-429.
10. Blanchet PJ, Fang J, Hyland K, Arnold LA, Mouradian MM, Chase TN (1999) Shortterm effects of high-dose 17beta-estradiol in postmenopausal PD patients: An crossover study. Neurology 53: 91-95.
11. Bondy SC (1995) The relation of oxidative stress and hyperexcitation to neurological disease. Proc Soc Exp Biol Med 208: 337-345.
12. Bosse R, DiPaolo T (1996) The modulation of brain dopamine and GABAA receptors by estradiol: A clue for CNS changes occurring at menopause. Cell Mol Neurobiol 16: 199-212.
13. Brinton RD, Proffitt P, Tran J, Luu R (1997a) Equilin, a principal component of the estrogen replacement therapy pre-marin, increases the growth of cortical neurons via an NMDA receptor-dependent mechanism. Exp Neurol 147: 211-220.
14. Brinton RD, Tran J, Proffitt P, Montoya M (1997b) 17beta-estradiol enhances the outgrowth and survival of neocortical neurons is culture. Neurochem Res 22: 1339-1351.
15. Campard PK, Crochemore C, Rerie F, Monnier D, Kock B, Loefiier JP (1997) PACAP type I receptor activation promotes cerebellar neuron survival through the CAMP/PKA s'tgnaling pathway. DNA Cell Biol 16: 323-333.
16. Chen J, Adachi N, Liu K, Arai T (1998) The effects of 17beta-estradiol on ischemiainduced neuronal damage in the gerbil hippocampus. Neuroscience 87: 817-822.
17. Choi DW (1992) Excitotoxic cell death. J Neurobiol 23: 1261-76.
18. Choi DW (1996) Ischemia-induced neuronal apoptosis. Curr Opin Neurobiol 6: 667-672.
19. Choi DW, Monyer H, Giffard RG, Goldberg MP, Christiane CW (1990) Acute brain injury, NMDA receptors, and hydrogen ions: observations in cortical cell cultures. Adv Exp Med Biol 268: 501-504.
20. Coyle JT, Puttfarcken P (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262: 689-695.
21. Culmsee C, Vedder H, Ravati A, Junker V, Otto D, Ahlemeyer B, Krieg J-C, Krieglstein J (1999) Neuroprotection by estrogens in a mouse model of focal cerebral ischemia and in cultured neurons: evidence for a receptor-independent antioxidative mechanism. J Cereb Blood Flow Metab 19: 1263-1269.
22. Cutolo M, Sulli A, Seriolo B, Accardo S, Masi AT (1995) Estrogens, the immune response and autoimmunity. Clin Exp Rheumatol 13: 217-226.
23. Cyr M, Calon F, Morissette M, Grandbois M, DiPaolo T, Callier S (2000a) Drugs with estrogen-like potency and brain activity: potential therapeutic application for the CNS. Cur Pharm Des 6: 1287-1312.
24. Cyr M, Ghribi O, DiPaolo T (2000b) Regional and selective effects of oestradiol and progesterone on NMDA and AMPA receptors in the rat brain. J Neuroendocrinol 12: 445-452.
25. Das A, Chaudhuri SK (1995) Effects of sex steroids on the concentrations of some brain neurotransmitters in male and female rats: Some new observations. Indian J Physiol Pharmacol 39: 223-230.
26. DiPaolo T (1994) Modulation of brain dopamine transmission by sex steroids. Rev Neurosci 5: 27-41.
27. D'Mello SR, Galli C, Ciotti T, Calissano P (1993) Induction of apoptosis in cerebellar granule neurons by low potassium: Inhibition of death by insulin-like growth factor I and cAMP. Proc Natl Acad Sci USA 90: 10989-10993.
28. Dodel RC, Du Y, Bales KR, Gao F, Paul SM (1999) Sodium salicylate and 17betaestradiol attenuate nuclear transcription factor NF-κB translocation in cultured rat astro-glial cultures following exposure to amyloid A beta(1-40) and lipopolysaccharides. J Neurochem 73: 1453-1460.
29. Dong L, Wang W, Wang F, Stoner M, Reed JC, Harigai M, Samudio L, Kladde MP, Vyhlidal C, Safe S (1999) Mechanisms of transcriptional activation of bcl-2 gene expression by 17beta-estradiol in breast cancer cells. J Biol Chem 274: 32099-32107.
30. Dubal DB, Shughrue PJ, Wilson ME, Merchenthaler I, Wise PM (1999) Estradiol modulates bcl-2 in cerebral ischemia: A potential rote for estrogen receptors. J Neurosci 19: 6385-6393.
31. Evans RM (1988) The steroid and thyroid hormone receptor superfamily. Science 240: 889-895.
32. Fink G, Sumner BE, McQueen JK, Wilson H, Rosie R (1998) Sex steroid control of mood, mental state and memory. Clin Exp Pharmacol Physiol 25: 764-775.
33. Fiorelli G, Gori F, Frediani U, Franceschelli F, Tanini A, Tosti-Guerra C, Benvenuti S, Gennari L, Becherini L, Brandi ML (1996) Membrane binding sites and nongenomic effects of estrogen in cultured human pre-osteoclastic cells. J Steroid Biochem Mol Biol 59: 233-240.
34. Foy MR, Xu J, Xie X, Brinton RD, Thompson RF, Berger TW (1999) 17beta-estradiol enhances NMDA receptor-mediated EPSPs and long-term potentiation. J Neurophysiol 81: 925-929.
35. Frölich L, Riederer P (1995) Free radical mechanisms in dementia of Alzheimer type and the potential for antioxidative treatment. Arzneimittelforschung. 45: 443-446.
36. Garcia-Segura LM, Cardona-Gomez P, Naftolin F, Chowen JA (1998) Estradiol upregulates Bcl-2 expression in adult brain neurons. Neuroreport 9: 593-597.
37. Gattaz WF, Behrens S, De Vry J, Häfner H (1992) Estradiol inhibits dopamine mediated behavior in rats - An animal model of sex-specific differences in schizophrenia. Fortschr Neurol Psychiatr 60: 8-16.
38. Gibbs RB (1994a) Estrogen and nerve growth factor-related systems in brain: effects an basal forebrain cholinergic neurons and implications for learning and memory processes and aging. Ann NY Acad Sci 743: 165-196.
39. Gibbs RB, Aggarwal P (1998) Estrogen and basal forebrain cholinergic neurons: Implications for brain aging and Alzheimer's disease-related cognitive decline. Horm Behav 34: 98-111.
40. Gibbs RB, Pfaff DW (1992) Effects of estrogen and fimbria/fornix transection on p75NGFR and ChAT expression in the medial septum and diagonal band of Broca. Exp Neurol 116: 23-39.
41. Gibbs RB, Wu D, Hersh LB, Pfaff DW (1994b) Effects of estrogen replacement on the relative levels of choline acetyltransferase, trkA, and nerve growth factor messenger RNAs in the basal forebrain and hippocampal formation of adult rats. Exp Neurol 129: 70-80.
42. Gollapudi L, Oblinger MM (1999) Estrogen and NGF synergistically protect terminally diffentiated, ERalpha-transfected PC12 cells from apoptosis. J Neurosci Res 56: 471-481.
43. Goodman Y, Bruce AJ, Cheng B, Mattson MP (1996) Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid betapeptide toxicity in hippocampal neurons. J Neurochem 66: 1836-44.
44. Green PS, Simpkins JW (2000) Neuroprotective effects of estrogens: potential mechanisms of action. Int J Devl Neuroscience 18: 347-358.
45. Green PS, Bishop J, Simpkins JW (1997a) 17alpha-estradiol exerts neuroprotective effects on SK-N-SH cells. J Neurosci 17: 511-515.
46. Green PS, Gordon K, Simpkins JW (1997b) Phenolic A ring requirement for the neuroprotective effects of steroids. J Steroid Biochem Mol Biol 63: 229-235.
47. Green PS, Gridley KE, Simpkins JW (1998) Nuclear estrogen receptor-independent neuroprotection by estratrienes: A novel interaction with glutathione. Neuroscience 84: 7-10.
48. Gridley KE, Green PS, Simpkins JW (1997) Low concentrations of estradiol reduce beta-Amyloid (25-35)-induced toxicity, lipid peroxidation and glucose utilization in human SK-N-SH neuroblastoma cells. Brain Res 778: 158-165.
49. Grossman CJ (1984) Regulation of the immune system by sex steroids. Endocr Rev 5: 435-455.
50. Gu G, Rojo AA, Zee MC, Jianhua Y, Simerly RB (1996a) Hormonal regulation of CREB phosphorylation in the anteroventral periventricular nucleus. J Neurosci 16: 3035-3044.
51. Gu Q, Moss RL (1996b) 17β-estradiol potentiates kainate-induced currents via activation of the cAMP cascade. J Neurosci 16: 3620-3629.
52. Gunaga KP, Menon KM (1973) Effect of catecholamines and ovarian hormones on cyclic AMP accumulation in rat hypothalamus. Biochem Biophys Res Commun 54: 440-448.
53. Gustafsson JA (2000) An update on estrogen receptors. Semin Perinatol 24: 66-69.
54. Gutteridge JM (1995) Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 41: 1819-1828.
55. Gutteridge JM, Halliwell B (2000) Free radicals and antioxidants in the year 2000. A historical look to the future. Ann NY Acad Sci 899: 136-147.
56. Häfner H, Behrens S, De Vry J, Gattaz WF (1991a) An animal model for the effects of estradiol on dopamine-mediated behavior: Implications for sex differences in schizophrenia. Psychiatry Res 38: 125-134.
57. Häfner H, Behrens S, De Vry J, Gattaz WF (1991b) Oestradiol anheances the vulnerability threshold for schizophrenia in women by an early effect on dopaminergic neurotransmission. Evidence from an epidemiological study and from animal experiments. Eur Arch Psychiatry Clin Neurosci 241: 65-68.
58. Hagiwara M, Shimomura A, Yoshida K, Imaki J (1996) Gene expression and CREB phosphorylation induced by cAMP and Ca2+ in neuronal cells. Adv Pharmacol 36: 277-285.
59. Hajimohammadreza I, Brammer M (1990) Brain membrane fluidity and lipid peroxidation in Alzheimer's disease. Neurosci Lett 112: 333-337.
60. Halbreich U, Rojansky N, Palter S, Tworek H, Hissin P, Wang K (1995) Estrogen augments serotonergic activity in postmenopausal women. Biol Psychiatry 37: 434-441.
61. Halliwell B (1992) Reactive oxygen species and the central nervous system. J Neurochem 59: 1609-1623.
62. Halliwell B, Gutteridge JM (1990) Role of free radicals and catytic metal ions in human disease: An overview. Methods Enzymol 186: 1-85.
63. Hardingham GE, Bading H (1998) Nuclear calcium: A key regulator of gene expression. Biometals 11: 345-358.
64. Hardy J, Allsop D (1991) Amyloid deposition as the central event in the etiology of Alzheimer's disease. Trends Pharmacol Sci 12: 383-388.
65. Harman D, Eddy DE, Noffsinger J (1976) Free radical theory of aging: Inhibition of amyloidosis in mice by antioxidants; possible mechanism. J Am Geriatr Soc 24: 203-210.
66. Hayashi T, Ishikawa T, Yamada K, Kuzuya M, Naito M, Hidaka H, Iguchi A (1994) Biphasic effect of estrogen on neuronal constitutive nitric oxide synthase via Ca(2+)-calmodulin dependent mechanism. Biochem Biophys Res Commun 203: 1013-1019.
67. Honda K, Sawada H, Kihara T, Urushitani M, Nakamizo T, Akaike A, Shimohama S (2000) Phosphatidylinositol 3-kinase mediates neuroprotection by estrogen in cultured cortical neurons. J Neurosci Res 60: 321-327.
68. Jansson L, Holmdahl R (1998) Estrogen-mediated immunosuppression in autoimmune diseases. Inflamm Res 47. 290-301.
69. Joels M, Karst H (1995) Effects of estradiol and progesterone on voltage-gated calcium and potassium conductances in rat CA1 hippocampal neurons. J Neurosci 15: 4289-4297.
70. Kawas C, Resnick S, Morrison A, Brookmeyer R, Corrada M, Zonderman A, Bacal C, Lingle DD, Metter E (1997) A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore Longitudinal Study of Aging. Neurology 48: 1517-1521.
71. Kelly MJ, Lagrange AH, Wagner EJ, Ronnekleiv OK (1999) Rapid effects of estrogen to modulate G protein-coupled receptors via activation of protein kinase A and protein kinase C pathways. Steroids 64: 64-75.
72. Kew JN, Smith DW, Sofroniew MV (1996) Nerve growth factor withdrawal induces the apoptotic death of developing septal cholinergic in vitro: protection by cyclic AMP analogue and high potassium. Neuroscience 70: 329-339.
73. Kim S, Liva SM, Dalal MA, Verity MA, Voskuhl RR (1999) Estriol ameliorates autoimmune demyelinating disease: Implications for multiple sclerosis. Neurology 52: 1230-1238.
74. Klinge CM (2000) Estrogen receptor interaction with co-Acivators and co-repressors. Steroids 65: 227-251.
75. Kobayashi Y, Shinozawa T (1997) Effect of dibutyryl cAMP and several reagents an apoptosis in PC12 cells induced by sialoglycopeptide from bovine brain. Brain Res 778: 309-317.
76. Korenman SG (1969) Comparative binding affinity of estrogens and its relation to estrogenic potency. Steroids 13: 163-177.
77. Kruman II, Pedersen WA, Springer JE, Mattson MP (1999) ALS-linked Cu/Zn-SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis. Exp Neurol 160: 28-39.
78. Lammers CH, D'Souza U, Qin ZH, Lee SH, Yajima S, Mouradian MM (1999) Regulation of striatal dopamine receptors by estrogen. Synapse 34: 222-227.
79. Leist M, Nicotera P (1998) Calcium and neuronal death. Rev Physiol Biochem Pharmacol 132: 79-125.
80. Lezoualc'h F, Behl C (1998) Transcription factor NF-kB: friend or foe of neurons? Mol Psychiatry 3: 15-20.
81. Matsuno A, Takekoshi S, Sanno N, Utsunomiya H, Ohsugi Y, Saito N, Kanemitsu H, Tamura A, Nagashima T, Osamura RY, Watanabe K (1997) Modulation of protein kinases and microtubule-Associated proteins and changes in ultrastructure in female rat pituitary cells: effects of estrogen and bromocriptine. J Histochem Cytochem 45: 805-813.
82. Mattsson MP, Rydel RE, Lieberburg I, Smith-Swintoskky VL (1993) Altered calcium signaling and neuronal injury: Stroke and Alzheimer's disease as examples. Ann NY Acad Sci 28: 679-721.
83. McEwen BS, Alves SE (1999) Estrogen actions in the central nervous system. Endocr Rev 20: 279-307.
84. McGeer EG, McGeer PL (1999) Brain inflammation in Alzheimer disease and the therapeutic inplications. Curr Pharm Des 5: 821-836.
85. McGeer PL, McGeer EG (1996) Anti-inflammatory drugs in the fight against Alzheimer's disease. Ann NY Acad Sci 777: 213-220.
86. McKay LI, Cidlowski JA (1998) Cross-talk between nuclear factor-κB and the steroid hormone receptors: mechanisms of mutual antagonism. Mol Endocrinol 12: 45- 56.
87. Mermelstein PG, Becker JB, Surmeier DJ (1996) Estradiol reduces calcium currents in rat neostriatal neurons via a membrane receptor. J Neurosci 16: 595-604.
88. Merry DE, Korsmeyer SJ (1997) Bcl-2 gene family in the nervous system. Annu Rev Neurosci 20: 245-267.
89. Michel MC, Rother A, Hiemke C, Graf R (1987) Inhibition of synaptosomal highaffinity uptake of dopamine and serotonin by estrogen agonists and antagonists. Biochem Pharmacol 36: 3175-3180.
90. Miller CP, Jirkovsky I, Hayhurst DA, Adelman SJ (1996) In vitro antioxidant effects of estrogens with a hindered 3-OH function on the copper-induced oxidation of low density lipoprotein. Steroids 61: 305-308.
91. Miller L, Hunt JS (1996) Sex steroid hormones and macrophage function. Life Sci 59: 1-14.
92. Minami T, Oomura Y, Nabekura J, Fukuda A (1990) 17beta-estradiol depolarization of hypothalamic neurons is mediated by cyclic AMP. Brain Res 519: 301-307.
93. Moosmann B, Behl C (1999) The antioxidant neuroprotective effects of estrogens and phenolic compounds are from their estrogenic properties. Proc Natl Acad Sci USA 96: 8867-8872.
94. Moosmann B, Behl C (2000) Cytoprotective antioxidant function of tyrosine and tryptophan residues in transmembrane proteins. Eur J Biochem 267: 5687-5692.
95. Mor G, Nilsen J, Horvath T, Bechmann I, Brown S, Garcia-Segura LM, Naftolin F (1999) Estrogen and microglia: A regulatory system that affects the brain. J Neurobiol 40: 484-496.
96. Morimoto BH, Koshland DE (1990) Induction and expression of long- And short-term neurosecretory potentiation in a neural cell line. Neuron 5: 875-880.
97. Mudd LM, Torres J, Lopez TF, Montague J (1998) Effects of growth factors and estrogen on the development of septal cholinergic neurons from the rat. Brain Res Bull 45: 137-142.
98. Mulnard RA, Cotman CW, Kawas C, van Dyck CH, Sano M, Doody R, Koss E, Pfeiffer E, Jin S, Gamst A, Grundman M, Thomas R, Thal LJ (2000) Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: A randomized controlled trial. Alzheimer's Disease Cooperative Study. JAMA 283: 1007-1015.
99. Murphy DD, Segal M (1996) Regulation of dendritic spine density in cultured rat hippocampal neurons by steroid hormones. J Neurosci 16: 4059-4068.
100. Nohl H (1993) Involvement of free radicals in ageing: A consequence or cause of senescence. Brit Med Bull 49: 653-667.
101. Olanow CW (1993) A radical hypothesis for neurodegeneration. Trends Neurosci 16: 439-444.
102. Pappolla MA, Omar RA, Kim KS, Robakis NK (1992) Immunhistochemical evidence of oxidative stress in Alzheimer's disease. Am J Pathol 140: 621-628.
103. Pardridge WM, Moeller TL, Mietus LJ, Oldendorf WH (1980) Blood-brain barrier transport and brain sequestration of steroid hormones. Am J Physiol 239: E96-E102.
104. Perillo B, Sasso A, Abbondanza C, Palumbo G (2000) 17beta-estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence. Mol Cell Biol 20: 2890-2901.
105. Piotrowski J, Pietras T, Kurmanowska Z, Nowak D, Marczak J, Marks-Konczalik J, Mazerant P (1996) Effect of paraquat intoxication ond ambroxol treatment on hydrogen peroxide production and lipid peroxidation in selected organs of the rat. J Appl Toxicol 16: 501-507.
106. Pozzo-Miller LD, Inoue T, Murphy DD (1999) Estradiol increases spine density and NMDA-dependent Ca2± transisents in spines of CA1 pyramidal neurons from hippocampal slices. J Neurophysiol 81: 1404-1411.
107. Racay P, Kaplan P, Lehotsky J (1996) Control of Ca2+ homeostasis in neuronal cells. Gen Physiol Biophys 15: 193-210.
108. Raevskii KS (1997) Brain dopamine receptors: Structure, functional role, and modulation by psychotropic substances. Vopr Med Khim 43: 553-565.
109. Razandi M, Pedram A, Greene GL, Levin ER (1999) Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: Studies of ERalpha and ERbeta expressed in Chinese hamster ovary cells. Mol Endocrinol 13: 307-319.
110. Regan RF, Guo Y (1997) Estrogens attenuate neuronal injury due to hemoglobin, chemical hypoxia, and excitatory amino acids in murine cortical cultures. Brain Res 764: 1333-1340.
111. Riecher-Rössler A, Häfner H (1993) Schizophrenia and oestrogens - is there an asssociation? Eur Arch Psych Clin Neurosci 242: 323-328.
112. Riecher-Rössler A, Häfner H, Stummbaum M, Maurer K, Schmidt R (1994) Can estradiol modulate schizophrenic symptomatology? Schizophr Bull 20: 203-214.
113. Ruiz-Larrea B, Leal A, Lacort M, de Groot H (1994) Antioxidant effects of estradiol and 2-hydroxyestradiol on iron-induced lipid peroxidation of rat liver microsomes. Steroids 59: 383-388.
114. Russell SR (1996) Nuclear hormone receptors and the Drosophila ecdysone response. Biochem Soc Symp 62: 111-121.
115. Saunders-Pullman R, Gordon-Elliott J, Parides M, Fahn S, Saunders HR, Bressman S (1999) The effect of estrogen replacement an early Parkinson's disease. Neurology 52: 1417-1421.
116. Sawada H, Ibi M, Kihara T, Urushitani M, Akaike A, Shimohama S (1998) Estradiol protects mesencephalic dopaminergic neurons from oxidative stress-induced neuronal death. J Neurosci Res 54: 707-719.
117. Schmidt R, Fazekas F, Reinhart B, Kapeller P, Fazekas G, Orfenbacher S, Eber B, Schumacher M, Freidl W (1996) Estrogen replacement therapy in older women: A neuropsychological and brain MRI study. J Am Geriatr Soc 44: 1307-1313.
118. Schneider LS, Farlow MR, Henderson VW, Pogoda JM (1996) Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease. Neurology 46: 1580-1584.
119. Sergeev PV, Vladimirov IA, Seifulla RD, Denisov IP, Rudnev IN (1974) The role of the chemical structure of steroid hormones in inhibiting peroxidative lipid oxidation in mitochondrial membranes. Vopr Med Khim 20: 359-362.
120. Shibata H, Spencer TE, Onate SA, Jenster G, Tsai SY, Tsai MJ, O'Malley BW (1997) Role of co-Activators and co-repressors in the mechanism of steroid/thyroid receptor action. Recent Prog Horm Res 52: 141-164.
121. Shughrue PJ, Lane MV, Merchenthaler I (1997) Comparative distribution of estrogen receptor-Alpha and -beta mRNA in the rat central nervous system. J Comp Neurol 388: 507-525.
122. Shyamal G, Guiot MC (1992) Activation of κB-specific proteins by estradiol. Proc Natl Acad Sci USA 89: 10628-10632.
123. Sies H (1997) Oxidative stress: oxidants and antioxidants. Exp Physiol 82: 291-295.
124. Singer CA, Rogers KL, Dorsa DM (1998) Modulation of Bcl-2 expression: A potential component of estrogen protection in NT2 neurons. Neuroreport 9: 2565-2568.
125. Singer CA, Rogers KL, Strickland TM, Dorsa DM (1996) Estrogen protects primary cortical neurons from glutamate toxicity. Neurosci Lett 212: 13-16.
126. Singh M, Meyer EM, Simpkins JW (1995) The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor mRNA expression in cortical an hippocampal brain regions of female Sprague Dawley rats. Endocrinology 136: 2320-2324.
127. Singh M, Setalo G Jr, Guan X, Warren M, Toran-Allerand CD (1999) Estrogen-induced activation of mitogen-Activated protein kinase in cerebral cortical explants: Convergence of estrogen and neurotrophin signaling pathways. J Neurosci 19: 1179-1188.
128. Smith MA, Perry G, Richey PL, Sayre LM, Anderson VE, Beal MF, Kowall N (1996) Oxidative damage in Alzheimer's. Nature 382: 120-121.
129. Sohrabji F, Greene LA, Miranda RC, Toran-Allerand CD (1994) Reciprocal regulation of estrogen and NGF receptors by their ligands in PC12 cells. J Neurobiol 25: 974-988.
130. Sohrabji F, Miranda R, Torran-Allerand CD (1995) Identification of a putative estrogen response element in the gene encoding brain-derived neurotrophic factor. Proc Natl Acad Sci USA 92: 11110-11114.
131. Sola C, Barron S, Tusell JM, Serratosa J (1999) The Ca2+/calmodulin signaling system in the neural response to excitability. Involvement of neuronal and glial cells. Prog Neurobiol 58: 207-232.
132. Stumpf WE, Jennes L (1984) The A-B-C (Allocortex-Brainstem-Core) circuitry of endocrine-Autonomic integration and regulation: A proposed hypothesis on the anatomical-functional relationships between estradiol sites of action and peptidergic- Aminergic neuronal systems. Peptides 5 (Suppl 1): 221-226.
133. Sugioka K, Shimosegawa Y, Nakano M (1987) Estrogens as natural antioxidants of membrane phospholipid peroxidation. FEBS Lett 210: 37-39.
134. Toran-Allerand CD, Singh M, Setalo G Jr (1999) Novel mechanisms of estrogen action in the brain: new players in an old story. Front Neuroendocrinol 20: 97-121.
135. Toung TJK, Traystman RJ, Hurn PD (1998) Estrogen-mediated neuroprotection after experimental stroke in male rats. Smoke 29: 1666-1670.
136. Tymianski M, Tator CH (1996) Normal and abnormal calcim homostasis in neurons: A basis for the pathophysiology of traumatic and ischemic central nervous system injury. Neurosurgery 38: 1176-1195.
137. Vedder H, Anthes N, Stumm G, Würz C, Behl C, Krieg J-C (1999) Estrogen hormones reduce lipid peroxidation in cells and tissues of the central nervous system. J Neurochem 72: 2531-2538.
138. Vedder H, Teepker M, Fischer S, Krieg J-C (2000) Chraracterization of the neuroprotective effects of estrogens on hydrogen peroxide-induced cell death in hippocampal HT22 cells: Time and dose-dependency. Exp Clin Endocrinol Diabetes 108: 120-127.
139. Vedder H, Weiß I, Holsboer F, Reul JMHM (1993) Glucocorticoid and mineralocorticoid receptors in rat neocortical and hippocampal brain cells in culture: Characterization and regulatory studies. Brain Res 605: 18-24.
140. Vossler MR, Yao H, York RD, Pan MG, Rim CS, Stork PJ (1997) cAMP activates MAP kinase and Elk-1 through a B-Raf- And Rap1-dependent pathway. Cell 89: 73-82.
141. Walton M, Sirimanne E, Williams C, Gluckman P, Dragunow M (1996) The role of the cyclic AMP-responsive element binding Protein (CREB) in hypoxic-ischemic brain damalte und repair. Mol Brain Res 43: 21-29.
142. Watters JJ, Dorsa DM (1998) Transcriptional effects of estrogen on neuronal neurotensin gene expression involve cAMP/protein kinase A-dependent signaling mechanisms. J Neurosci 18: 6672-6680.
143. Watters JJ, Campbell JS, Cunnfngham MJ, Krebs EG, Dorsa DM (1997) Rapid membrane effects of steroids in neuroblastoma cells: effects of estrogen a mitogen actived Protein kinase signalling cascade und c-fos immediate early gene transcription. Endocrinology 138: 4030-4033.
144. Weaver CE Jr, Park-Chung M, Gibbs TT, Farb DH (1997) 17beta-estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors. Brain Res 761: 338-341.
145. Weiland NG (1992) Glutamic acid decarboxylase messenger ribonucleic acid is regulated by estradiol and progesterone in the hippocampus. Endocrinology 131: 2697-2702.
146. Weiss DJ, Gurpide E (1988) Non-genomic effects of estrogens and antiestrogens. J Steroid Biochem 31: 671-676.
147. Wiese TE, Polin LA, Palomino E, Brooks SC (1997) Induction of the estrogen specific mitogenic response of MCF-7 cells by selected analogues of estradiol-17beta: A 3D QSAR study. J Med Chem 40: 3659-3669.
148. Wolozin B, Behl C (2000) Mechanisms of neurodegenerative disorders. Part 2: Control of cell death. Arch Neurol 57: 801-804.
149. Wong M, Moss RL (1992) Long-term and short-term electrophysiological effects of estrogen on the synaptic properties of hippocampal CA1 neurons. J Neurosci 12: 3217-3225.
150. Woolley CS, McEwen BS (1994) Estradiol regulates hippocampal dendritic spine density via an NMDA receptor dependent mechanism. J Neurosci 19: 379-386.
151. Woolley CS, Weiland NG, McEwen BS, Schwartzkroin PA (1997) Estradiol increases the sensitivity of hippocampal CAl pyramidal cells to NMDA receptor-mediated synaptic input: Correlation with dendritic spine density. J Neurosci 17: 1848-1859.
152. Yamashita S (1998) Localization and functions of steroid hormone receptors. Histol Histopathol 13: 255-70.
153. Yang S-H, Shi J, Day AL, Simpkins JW (2000) Estradiol exerts neuroprotective effects when administered after ischemic insult. Stroke 31: 75-79.
154. Yankner BA (1996) Mechanism of neuronal degeneration in Alzheimer's disease. Neuron 16: 921-932.